A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma

Published:2015-09-02 Issue:11 Volume:14 Page:2569-2575
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Amaravadi Ravi K.,Schilder Russell J.,Martin Lainie P.,Levin Myron,Graham Martin A.,Weng David E.,Adjei Alex A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy;Cancer Immunology, Immunotherapy;2024-08-06

2. Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials;ESMO Open;2024-08

3. ARTS and small-molecule ARTS mimetics upregulate p53 levels by promoting the degradation of XIAP;Apoptosis;2024-04-29

4. Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation;International Journal of Molecular Sciences;2024-03-25

5. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer;Journal of Cancer Research and Clinical Oncology;2024-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP